Invacare leads growing oxygen market in Europe

Thursday, September 12, 2013

VANCOUVER, British Columbia – Europe’s 59 million Euro oxygen therapy market is expected to grow as the continent’s population ages and former smokers develop lung disease, iData Research reported recently. “Among western European countries, France has the largest number of patients on long-term oxygen therapy, and the extensive use of oxygen concentrators is encouraged by some of the highest reimbursement rates in Europe,” said Kamran Zamanian, CEO of iData, in a press release. Conversely, the Italian reimbursement and regulatory system favors liquid oxygen, the report says. Invacare holds more than half the overall market share in Europe, according to the report, followed by Philips Respironics, Devilbiss, AirSep, Inogen One and SeQual.